Cash Flow Statement

Daily Values

Growth Metrics

Assets Growth (3y)Assets Growth (5y)Cash & Equivalents Growth (1y)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Total Debt Growth (1y)

Income Statement

Others

Ratios

Regencell Bioscience Holdings (RGC) Cash & Equivalents Growth (3y) (2023 - 2024)